Assessing the Hemodynamic Benefits of Cardiac Resynchronization Therapy in Children Following Open-Heart Surgery
Study Details
Study Description
Brief Summary
Malformations of the heart (congenital heart disease) are the most common congenital birth defects, occurring in about 1% of children. Each year, between 150-200 children will undergo open heart surgery at British Columbia Children's Hospital (BCCH) to repair the defect(s) in their heart. The abnormal structure of the heart or the open heart surgery may cause damage to the electrical system of the heart which can disturb the rhythm of the heart (arrhythmias), prolong recovery or be life-threatening. For this reason, temporary pacing wires are placed in the heart following surgery to ensure the heart rhythm is as normal as possible during the post-operative period (pacing). In recent years, scientists have recognized that pacing the heart from one area is not necessarily the same as pacing it from a different area. In fact, in some individuals with arrhythmias and poor heart function, pacing the heart from different areas can improve the pumping of the heart, resulting in better heart function. This form of treatment is called Cardiac Resynchronization Therapy (CRT) because it endeavours to optimize the pumping of the heart by changing the electrical activation of the heart. CRT has been used to a very limited extent in children. A few pediatric cardiologists have used CRT to help children who are in heart failure. We would like to determine whether pacing the heart from different areas after open heart surgery improves the child's heart function and aids his or her recovery.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
The heart's rhythmic beating or contraction is determined by the flow of an excitatory electrical wave-front along a specialized cardiac conduction system. In the presence of altered conduction, such as a bundle branch block or an intra-ventricular conduction delay, abnormal cardiac contraction or dyssynchrony occurs. The delay can occur in the specialized conduction system (electrical dyssynchrony) or myocardium (mechanical or structural dyssynchrony).1 Techniques to improve both electrical and mechanical synchrony in patients with bundle branch block were initially done on adults. Research in this field began to appear in the last decade when dual chamber pacing was first used as adjunctive therapy for adults with medically refractory heart failure.2 Acute studies showed that atrioventricular (AV) synchronous pacing with a short AV delay improved cardiac output and exercise duration in patients with heart failure and a prolonged PR interval.3 The beneficial effects of AV resynchrony (optimizing AV conduction times with pacing) were shown to be due to increased diastolic filling time, and reduction in mitral or tricuspid valve regurgitation. The results of long-term studies, however, did not demonstrate consistent improvement in ejection fraction or NYHA functional class with DDD pacing.4 Since then, Cardiac Resynchronization Therapy (CRT) has established itself as a proven therapy for congestive heart failure in adults, with patients showing improvement in exercise tolerance, quality of life, and survival.1, 5, 6 More recently, the technique of utilizing CRT to stimulate the heart from novel or multiple sites has been applied to pediatric patients.7-9 Children with chronic heart failure have received CRT successfully as an adjunctive therapy.
One of the major limitations of CRT is the objective assessment of whether cardiac output and ventricular function are improved. As well, the precise location of where to pace the heart in order to optimize hemodynamic function needs to be determined. The objective assessment of successful CRT is a difficult clinical issue and should ideally be performed non-invasively. Traditional two-dimensional echocardiographic and Doppler indices have been used to assess the efficacy of CRT and include measuring cardiac output, looking at ventricular ejection times, visually assessing wall motion, and measuring the length of diastole using the mitral "E" and "A" waves. As most of the existing techniques are limited to assessing global function, more detailed methods of assessment are necessary in order to fully assess and optimize CRT.10, 11 Tissue Doppler Imaging (TDI) offers a more detailed analysis of regional cardiac function and allows quantitative measures to be obtained. TDI operates at high frame rates and can non-invasively map cardiac activation and add information related to the degree and location of cardiac dyssychrony. TDI and its derivatives allow: (1) measurement of myocardial velocities, which is based on the detection of the Doppler shift caused by the motion of myocardial tissue during the cardiac cycle; (2) visualization of tissue tracking, which color-codes tissue segments with similar displacements according to a color map; (3) measurement of regional strain rates, which describes the rate of deformation, or how quickly a segment of tissue shortens or lengthens; and (4) measurement of regional strain, which describes the deformation of an object (in this case, tissue) relative to its original state. 12, 13
Cardiac pacing in children is done most often following cardiac surgery for congenital heart disease (CHD). This pacing is usually temporary. Following open heart surgery children frequently exhibit cardiac dyssynchrony secondary to conduction abnormalities or regional wall motion abnormalities. Often, damage to the conduction system is an unavoidable result of the operation itself. Regardless of the extent of the conduction abnormality, most patients operated on for congenital heart disease undergo a period of decreased cardiac function related to several factors, including: pre-existing myocardial disease; cardiopulmonary bypass; and residual cardiac lesions.7, 14 The decrease in cardiac performance and, therefore, the risk to the patient's life, can be aggravated by the presence of cardiac dyssynchrony. The benefits of CRT are just beginning to receive attention in the setting of pediatric post-operative cardiac care. 15
We hope to demonstrate that CRT is beneficial in the care of post-operative patients undergoing open-heart surgery for repair of congenital heart defects. We will be using state-of-the-art TDI for assessing cardiac dyssynchrony, and using it as a tool for monitoring therapy. This study has tremendous potential for application to all patients undergoing open-heart surgery for repair of congenital heart defects. If it can be demonstrated that CRT can improve post-operative outcomes in this population, significant morbidity and mortality can be avoided, Intensive Care Unit (ICU) and hospital stays shortened, and the associated health care costs reduced.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Congenital Heart Surgery Patients Pacing protocol prior to patient's extubation with 20 min. of either conventional right ventricular (RV) or biventricular (BiV) pacing, preceded and followed by 10 min. of recovery time. |
Procedure: Congenital Heart Surgery Patients
undergoing either Biventricular (BiV) pacing or Right Ventricular (RV) Pacing
|
Outcome Measures
Primary Outcome Measures
- Cardiac Index [Baseline and after 20 minutes of pacing]
Secondary Outcome Measures
- Systolic Blood Pressure []
- Incidence of Low Output Syndrome []
- TDI Indices (Tissue Velocities, Tissue Tracking, Regional Strain, and Regional Strain Rates) []
- Inotropic Support []
- Ventilatory Support []
- QRS Duration [Baseline and after 20 minutes of pacing]
- Cardio-pulmonary Bypass Time [Baseline and after 20 minutes]
Eligibility Criteria
Criteria
Inclusion Criteria:
Subjects will be eligible for enrollment in this study if they are undergoing cardiopulmonary bypass surgery for right or left ventricular surgery or biventricular surgery and (1) have intra-cardiac conduction delay or bundle branch block post-surgery; (2) have echocardiographic evidence of ventricular dyssynchrony; (3) have pre-existing conduction disease or bundle branch block; or (4) have pre-existing ventricular dyssynchrony.
Exclusion Criteria:
Subjects will be excluded if they: (1) have single ventricle morphology; (2) require post-operative ECMO; (3) have sustained atrial or ventricular arrhythmias that may complicate ventricular pacing; (4) are not able to have functioning epicardial pacemaker leads; (5) are, in the opinion of the intensivist, cardiologist or surgeon, not stable enough medically to participate in the study; or (6) are unwilling to provide informed consent or assent.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Children's Heart Centre, British Columbia's Children's Hospital | Vancouver | British Columbia | Canada | V6H 3V4 |
Sponsors and Collaborators
- University of British Columbia
Investigators
- Principal Investigator: Shubhayan Sanatani, MD, Provincial Health Services Authority
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- H03-70642
- H03-70642
Study Results
Participant Flow
Recruitment Details | 34 patients were recruited between October 1, 2006 and May 31, 2008. |
---|---|
Pre-assignment Detail | One patient was excluded due to pacing wire malfunction. Four consented but we were not able to adequately capture and pace their left ventricle intraoperatively. Two consented, but underwent early extubation, and we were not able to perform the study in time. One family withdrew from the study. One patient had poor echocardiographic windows. |
Arm/Group Title | Congenital Heart Disease Pts. Undergoing Biventricular Repair |
---|---|
Arm/Group Description | Pacing protocol prior to patient's extubation with 20 min. of conventional right ventricular (RV), preceded and followed by 10 min. of recovery time. |
Period Title: Overall Study | |
STARTED | 34 |
COMPLETED | 25 |
NOT COMPLETED | 9 |
Baseline Characteristics
Arm/Group Title | Congenital Heart Disease Patients |
---|---|
Arm/Group Description | Pacing protocol prior to patient's extubation with 20 min. of conventional right ventricular (RV), preceded and followed by 10 min. of recovery time. |
Overall Participants | 25 |
Age (Count of Participants) | |
<=18 years |
25
100%
|
Between 18 and 65 years |
0
0%
|
>=65 years |
0
0%
|
Age (months) [Median (Full Range) ] | |
Age, Continuous |
5.2
|
Sex: Female, Male (Count of Participants) | |
Female |
14
56%
|
Male |
11
44%
|
Region of Enrollment (participants) [Number] | |
Canada |
25
100%
|
Outcome Measures
Title | Cardiac Index |
---|---|
Description | |
Time Frame | Baseline and after 20 minutes of pacing |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Baseline | BiV Pacing | RV Pacing |
---|---|---|---|
Arm/Group Description | Cardiac Index at baseline. | Cardiac Index when patient's extubation with 20 min. of biventricular pacing | Cardiac Index when patient's extubation with 20 min. of right ventricular pacing |
Measure Participants | 25 | 25 | 25 |
Median (Full Range) [L/min/m2] |
3.39
|
3.42
|
3.23
|
Title | Systolic Blood Pressure |
---|---|
Description | |
Time Frame |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title |
---|
Arm/Group Description |
Title | Incidence of Low Output Syndrome |
---|---|
Description | |
Time Frame |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title |
---|
Arm/Group Description |
Title | TDI Indices (Tissue Velocities, Tissue Tracking, Regional Strain, and Regional Strain Rates) |
---|---|
Description | |
Time Frame |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title |
---|
Arm/Group Description |
Title | Inotropic Support |
---|---|
Description | |
Time Frame |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title |
---|
Arm/Group Description |
Title | Ventilatory Support |
---|---|
Description | |
Time Frame |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title |
---|
Arm/Group Description |
Title | QRS Duration |
---|---|
Description | |
Time Frame | Baseline and after 20 minutes of pacing |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Baseline | BiV Pacing | RV Pacing |
---|---|---|---|
Arm/Group Description | QRS duration at baseline | QRS duration when patient's extubation with 20 min. of biventricular pacing | QRS duration when patient's extubation with 20 min. of right ventricular pacing |
Measure Participants | 25 | 25 | 25 |
Median (Full Range) [ms] |
80
|
100
|
100
|
Title | Cardio-pulmonary Bypass Time |
---|---|
Description | |
Time Frame | Baseline and after 20 minutes |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Congenital Heart Disease Pts. Undergoing Biventricular Repair |
---|---|
Arm/Group Description | Pacing protocol prior to patient's extubation with 20 min. of conventional right ventricular (RV), preceded and followed by 10 min. of recovery time. |
Measure Participants | 25 |
Median (Full Range) [min.] |
96
|
Adverse Events
Time Frame | ||
---|---|---|
Adverse Event Reporting Description | ||
Arm/Group Title | Pacing Protocol and RV Pacing | |
Arm/Group Description | Pacing protocol prior to patient's extubation with 20 min. of conventional right ventricular (RV), preceded and followed by 10 min. of recovery time. | |
All Cause Mortality |
||
Pacing Protocol and RV Pacing | ||
Affected / at Risk (%) | # Events | |
Total | / (NaN) | |
Serious Adverse Events |
||
Pacing Protocol and RV Pacing | ||
Affected / at Risk (%) | # Events | |
Total | 0/11 (0%) | |
Other (Not Including Serious) Adverse Events |
||
Pacing Protocol and RV Pacing | ||
Affected / at Risk (%) | # Events | |
Total | 0/11 (0%) |
Limitations/Caveats
More Information
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Dr. Shubhayan Sanatani |
---|---|
Organization | University of British Columbia |
Phone | 6048752345 ext 7955 |
ssanatani@cw.bc.ca |
- H03-70642
- H03-70642